01:40a | Japan stocks end higher on hopes of economic rebound | RE |
01:32a | NOVARTIS : Says Canakinumab Didn't Meet Primary Endpoint in Phase 3 Trial for L.. | DJ |
01:14a | NOVARTIS' : canakinumab doesn't meet primary endpoint in phase III study | RE |
01:00a | PRESS RELEASE : Novartis provides update on Phase -2- | DJ |
01:00a | PRESS RELEASE : Novartis provides update on Phase III study evaluating canakinu.. | DJ |
01:00a | NOVARTIS : provides update on Phase III study evaluating canakinumab (ACZ885) a.. | DJ |
03/08 | TERUMO : Japan's Terumo says makes syringe to draw 7 doses from Pfizer vaccine .. | RE |
03/08 | ASTRAZENECA : Indonesia approves AstraZeneca vaccine for emergency use | RE |
03/08 | Japanese shares rise amid stock rotation ahead of financial year-end | RE |
03/08 | MODERNA : COVID SCIENCE-Vaccine response may be weaker in elderly; Merck drug s.. | RE |
03/08 | MERCK : Positive Phase 1 Data for Islatravir Subdermal Implant for HIV-1 Preven.. | DJ |
03/08 | MODERNA : Fully vaccinated people can gather without masks indoors, should stil.. | RE |
03/08 | WHO says influenza-like illness post COVID-19 vaccinations expected side effe.. | RE |
03/08 | ASTRAZENECA : Berenberg reiterates its Buy rating | MD |
03/08 | MODERNA : REFILE-UPDATE 1-Moderna taps Baxter to support fill and finish of 60-.. | RE |
03/08 | ZOETIS : Raymond James Upgrades Zoetis to Outperform From Market Perform; Price.. | MT |
03/08 | ZOETIS : BofA Securities Upgrades Zoetis to Buy From Neutral; Price Target is $.. | MT |
03/08 | ROCHE HOLDINGS AG : Gets a Neutral rating from UBS | MD |
03/08 | VIATRIS : Goldman Sachs Downgrades Viatris to Neutral From Buy, Adjusts Price T.. | MT |
03/08 | ASTRAZENECA : Barclays Lifts AstraZeneca PT, Keeps Overweight Rating | MT |
03/08 | ASTRAZENECA : Barclays gives a Buy rating | MD |
03/08 | VIFOR PHARMA : Mirabaud Securities Lifts Price Target on Vifor Pharma, Maintain.. | MT |
03/08 | PRESS RELEASE : Fifteenth Annual BIO-Europe Spring Digital to bring together 2,5.. | DJ |
03/08 | India seeks funds from Quad alliance to match China's vaccine push | RE |
03/08 | Vaccine developer SK Bioscience to raise $1.3 billion in S.Korea's largest IP.. | RE |
03/08 | MERCK KGAA : Goldman Sachs reiterates its Sell rating | MD |
03/08 | ROCHE : Withdraws Bladder-Cancer Indication for Tecentriq in US | DJ |
03/08 | Roche joins AstraZeneca in ditching U.S. bladder cancer indication for immuno.. | RE |
03/08 | SINOVAC BIOTECH : Malaysia to buy more Pfizer-BioNTech vaccines | RE |
03/08 | PRESS RELEASE : Roche provides update on Tecentriq US indication in prior-platin.. | DJ |
03/07 | ASTRAZENECA : Japan COVID-19 inoculations off to snail pace start due to vaccin.. | RE |
03/07 | NIPPON TELEGRAPH AND TELEPHONE : Japan minister apologises for bureaucrat's din.. | RE |
03/07 | ASTRAZENECA : Vietnam begins COVID-19 vaccinations after successful virus conta.. | RE |
03/07 | MODERNA : U.S. says Russian-backed outlets spread COVID-19 vaccine 'disinformat.. | RE |
03/07 | ASTRAZENECA : Oxford Covid-19 Vaccine Startup in Conflict with University Ahead.. | DJ |
03/07 | Having Trouble Getting the Covid Vaccine? Your Company Might Soon Offer It. | DJ |
03/06 | NHS England invites people aged 56 to 59 to book COVID-19 vaccinations in com.. | RE |
03/06 | U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vacci.. | DJ |
03/06 | U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vacci.. | DJ |
03/06 | U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vacci.. | DJ |
03/06 | MODERNA : U.S. scientists doubtful of one-shot regimen for Pfizer, Moderna COVI.. | RE |
03/06 | MERCK : Covid-19 Pill Shows Promise in Preliminary Testing | DJ |
03/06 | CHECK POINT SOFTWARE TECHNOLOGIES : In Covid-19 Battle, Israeli Employers Offer.. | DJ |
03/05 | ELI LILLY AND : AbCellera's Covid-19 Treatment Gets Recommendation From Europea.. | DJ |
03/05 | ELI LILLY AND : Gets CHMP Positive Opinion for Covid-19 Treatments | DJ |
03/05 | PERRIGO : Morgan Stanley Adjusts Perrigo Company PT to $45 From $53, Maintains .. | MT |
03/05 | AMGEN : SVB Leerink Adjusts Price Target on Amgen to $260 From $252, Maintains .. | MT |
03/05 | AMGEN : Morgan Stanley Adjusts Price Target on Amgen to $279 From $277, Maintai.. | MT |
03/05 | AMGEN : Barclays Adjusts Amgen's Price Target to $230 From $242, Keeps Equal-We.. | MT |
03/05 | ASTRAZENECA : Indian vaccine giant SII warns of supply hit from U.S. raw materi.. | RE |